https://r3i.org/landmark-real-world-evidence-informs-trial-design-for-triglyceride-lowering-therapies/ 2026-04-08T15:24:31Z R3I en Landmark  – Real-world evidence informs trial design for triglyceride-lowering therapies 2026-04-08T15:24:31Z Blog https://r3i.org/landmark-real-world-evidence-informs-trial-design-for-triglyceride-lowering-therapies/ 2026-04-08T15:24:34Z R3I en 大血管リスク – リアルワールドエビデンスがトリグリセリド低下療法の試験デザインに情報を提供する 2026-04-08T15:24:31Z Blog https://r3i.org/landmark-real-world-evidence-informs-trial-design-for-triglyceride-lowering-therapies/ 2026-04-08T15:24:34Z R3I en Landmark – Datos del mundo real aportan información para el diseño de los ensayos que evalúan los tratamientos de reducción de triglicéridos 2026-04-08T15:24:31Z Blog https://r3i.org/focus-target-both-triglycerides-and-inflammation-in-secondary-stroke-prevention/ 2026-04-08T14:55:41Z R3I en Focus  – Target both triglycerides and inflammation in secondary stroke prevention 2026-04-08T14:55:41Z Blog https://r3i.org/focus-target-both-triglycerides-and-inflammation-in-secondary-stroke-prevention/ 2026-04-08T14:55:44Z R3I en フォーカス　大血管リスク 2026-04-08T14:55:41Z Blog https://r3i.org/focus-target-both-triglycerides-and-inflammation-in-secondary-stroke-prevention/ 2026-04-08T14:55:44Z R3I en Enfoque en el riesgo macrovascular 2026-04-08T14:55:41Z Blog https://r3i.org/r3i-editorial-02-26/ 2026-04-07T15:51:11Z R3I en R3i Editorial 02/26 2026-04-07T15:51:11Z Blog https://r3i.org/r3i-editorial-02-26/ 2026-04-07T15:53:00Z R3I en R3i Editorial 02/26 2026-04-07T15:51:11Z Blog https://r3i.org/r3i-editorial-02-26/ 2026-04-07T15:55:25Z R3I en R3i Editorial 02/26 2026-04-07T15:51:11Z Blog